HeyJaredGerard Gallagher
- Indexed articles, last 90 days
- 11
- Latest publication
- Sep 11, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 17, 2026
Latest articles
Officials declare end to largest US outbreak of Cyclospora (opens the original)
Read excerpt
Federal health officials on Friday declared an end to the largest recorded outbreak of cyclosporiasis in United States history. CDC and FDA websites tracking the outbreak were updated mid-morning to say that it was over after more than 2 months. Although the FDA said it would continue investigating the outbreak, which was traced to iceberg lettuce sourced from central Mexico by Taylor Farms, the agencies noted that there has been a sharp decline in cases, and that stores and restaurants should h
FDA approves smallest single-pill HIV regimen, Bixlenvo (opens the original)
Read excerpt
The FDA has approved Bixlenvo, the first single-pill daily HIV therapy for adults being successfully treated on more complex regimens who are unable to take other available single-tablet HIV medications. The accelerated approval was announced by Gilead Sciences, which developed the single-tablet regimen combining two of its existing drugs: In an email, Gilead said the new combination âwill be especially impactful for those aging with HIVâ who rely on complex regimens that require multiple pi
FDA extends approval of Tivicay to treat newborns with HIV (opens the original)
Read excerpt
The FDA has extended its approval of dolutegravir tablets for oral suspension to treat newborns with HIV. Dolutegravir tablets (Tivicay, ViiV Healthcare) and dolutegravir tablets for oral suspension (Tivicay PD, ViiV) were previously approved for adults and infants aged at least 4 weeks and weighing 3 kg or more. Now, Tivicay PD will also be available to treat HIV in infants weighing at least 2 kg from birth up to age 4 weeks, the FDA announced Tuesday. According to the agency, the approval was
Once-weekly HIV pill shines in phase 3 trials (opens the original)
Read excerpt
People with HIV who switched from daily medication to an investigational once-weekly pill containing islatravir and lenacapavir remained virally suppressed on the new combination, according to the results of two phase 3 trials. The findings, presented recently at the International AIDS Conference in Rio de Janeiro and published in The New England Journal of Medicine, were “highly anticipated,” International AIDS Society president Kenneth Ngure, PhD, MPH, told reporters. Choice has become a vital
Salmonella outbreak linked to jalapeños sickens hundreds in US (opens the original)
Read excerpt
Health officials linked an outbreak of Salmonella that has sicked 345 people in 27 states to jalapeño peppers sourced from Mexico and distributed to restaurants and wholesalers in the United States. There have been 36 hospitalizations and no deaths in the outbreak, the CDC and FDA said this week. The implicated peppers were grown in Sinaloa, Mexico, and distributed in the U.S. by San Diego-based Coast Citrus Distributors, which has agreed to recall the peppers, health officials said. According
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.